Send us a Text Message.

The Davos Alzheimer's Collaborative ( DAC - https://www.davosalzheimerscollaborative.org/ ) is a pioneering worldwide initiative to cure Alzheimer’s disease and dementia, seeking to mirror the success of global efforts against infectious diseases such as HIV/AIDS, Covid, and Malaria. Absent effective action at scale around the world, by 2050, more than 150 million families and half a billion people will be personally impacted by Alzheimer’s, creating a social, financial, economic, and global security disaster of historic proportions. DAC was launched in Davos in 2021 by the World Economic Forum and the Global CEO Initiative on Alzheimer's Disease.

Dr. Tim MacLeod is the Director of the Systems Preparedness workstream of the Davos Alzheimer’s Collaborative (DAC) where he executes on a mission to facilitate the implementation of national, regional, and global commitments to provide access to future innovations in treatment, diagnosis, and care.

Drawing on his background in implementation science and innovation consulting, Dr. MacLeod guides the development, execution, and dissemination of multi-site, real-world implementation studies that generate evidence about the facilitators and barriers to adopting and scaling novel technology in the ADRD space.

Before joining DAC, Dr. MacLeod led the award-winning human-centered design studio Bridgeable as Managing Director, where he worked with Fortune 500 companies in the financial service and health spaces on significant innovation initiatives.

Dr. MacLeod holds a Ph.D. in community psychology and has published widely on health innovation and implementation science. His research with the Mental Health Commission of Canada’s At Home/Chez Soi team scaled the Housing First model from 5 pilot sites to over 20 cities nationally through multi-level policy change.

Dr. Vaibhav Narayan is Executive Vice President at the Davos Alzheimer’s Collaborative (DAC), which he joined after 13+ years at Johnson & Johnson (J&J) where he was Vice President of Digital Health Innovation and Head of Data Science for Neuroscience R&D.

At J&J, Dr. Narayan created and led programs that utilized multi-modal data from ‘genomics to digital’ to understand disease subtypes and develop AI/ML driven digital health solutions for prevention, early detection, disease course monitoring and prediction in Alzheimer’s and neuropsychiatric diseases.

Dr. Narayan also previously served as Head, Discovery Informatics, Eli Lilly and Company, and as Director, Computational Sciences, Celera Genomics. He also currently serves a role as Chief Industry Officer, UK Mental Health Mission, University of Oxford.

Dr. Narayan obtained a PhD from Yale University in computational biology and an Executive MBA from Kellogg School of Management, Northwestern University.

Important Episode Links

The Davos Alzheimer’s Collaborative Healthcare System Preparedness
(DAC-SP) Early Detection Blueprint - https://www.dacblueprint.org/

Alzheimer's Association International Conference 2024 - https://aaic.alz.org/

#Alzheimers #Dementia #Davos #Neurology #Neuroscience #HealthyAging #BrainHealth #TimMacLeod #VaibhavNarayan #DavosAlzheimersCollaborative #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research

Support the Show.